Tobias Strunz, PhD
Advertisement

Tobias Strunz, PhD, is from Research & Early Development, Bayer AG, Wuppertal, Germany
Articles by Tobias Strunz, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
Johnson & Johnson to acquire Ollin Biosciences in deal worth up to $3.3 billion
2
Dazodalibep data put Sjögren screening in focus for ophthalmologists
3
Q&A: What the FDA’s class-wide NAION warning on GLP-1s means for eye care
4
Q&A: Caroline R. Baumal, MD, from academic retina to the C-suite and back | Eichenbaum Acorns
5
